Request for Covid-19 Impact Assessment of this Report
The United States Gene Therapy Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gene Therapy Drugs market, reaching US$ million by the year 2028. As for the Europe Gene Therapy Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gene Therapy Drugs players cover F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., and Ultragenyx Pharmaceutical,Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Neuromuscular Disease
Genetic Disease
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche AG
Novartis International AG
Gilead Sciences, Inc.
Ultragenyx Pharmaceutical,Inc.
Applied Genetic Technologies Corp
Audentes Therapeutics
BioMarin Pharmaceutical
Bluebird Bio
Nightstar Therapeutics
Sangamo Therapeutics
Spark Therapeutics
uniQure
VBL Therapeutics
Voyager Therapeutics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapy Drugs Market Size 2017-2028
2.1.2 Gene Therapy Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gene Therapy Drugs Segment by Type
2.2.1 Neuromuscular Disease
2.2.2 Genetic Disease
2.2.3 Other
2.3 Gene Therapy Drugs Market Size by Type
2.3.1 Gene Therapy Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gene Therapy Drugs Market Size Market Share by Type (2017-2022)
2.4 Gene Therapy Drugs Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Gene Therapy Drugs Market Size by Application
2.5.1 Gene Therapy Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gene Therapy Drugs Market Size Market Share by Application (2017-2022)
3 Gene Therapy Drugs Market Size by Player
3.1 Gene Therapy Drugs Market Size Market Share by Players
3.1.1 Global Gene Therapy Drugs Revenue by Players (2020-2022)
3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Gene Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gene Therapy Drugs by Regions
4.1 Gene Therapy Drugs Market Size by Regions (2017-2022)
4.2 Americas Gene Therapy Drugs Market Size Growth (2017-2022)
4.3 APAC Gene Therapy Drugs Market Size Growth (2017-2022)
4.4 Europe Gene Therapy Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Gene Therapy Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gene Therapy Drugs Market Size by Country (2017-2022)
5.2 Americas Gene Therapy Drugs Market Size by Type (2017-2022)
5.3 Americas Gene Therapy Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy Drugs Market Size by Region (2017-2022)
6.2 APAC Gene Therapy Drugs Market Size by Type (2017-2022)
6.3 APAC Gene Therapy Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gene Therapy Drugs by Country (2017-2022)
7.2 Europe Gene Therapy Drugs Market Size by Type (2017-2022)
7.3 Europe Gene Therapy Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gene Therapy Drugs by Region (2017-2022)
8.2 Middle East & Africa Gene Therapy Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Gene Therapy Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gene Therapy Drugs Market Forecast
10.1 Global Gene Therapy Drugs Forecast by Regions (2023-2028)
10.1.1 Global Gene Therapy Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Gene Therapy Drugs Forecast
10.1.3 APAC Gene Therapy Drugs Forecast
10.1.4 Europe Gene Therapy Drugs Forecast
10.1.5 Middle East & Africa Gene Therapy Drugs Forecast
10.2 Americas Gene Therapy Drugs Forecast by Country (2023-2028)
10.2.1 United States Gene Therapy Drugs Market Forecast
10.2.2 Canada Gene Therapy Drugs Market Forecast
10.2.3 Mexico Gene Therapy Drugs Market Forecast
10.2.4 Brazil Gene Therapy Drugs Market Forecast
10.3 APAC Gene Therapy Drugs Forecast by Region (2023-2028)
10.3.1 China Gene Therapy Drugs Market Forecast
10.3.2 Japan Gene Therapy Drugs Market Forecast
10.3.3 Korea Gene Therapy Drugs Market Forecast
10.3.4 Southeast Asia Gene Therapy Drugs Market Forecast
10.3.5 India Gene Therapy Drugs Market Forecast
10.3.6 Australia Gene Therapy Drugs Market Forecast
10.4 Europe Gene Therapy Drugs Forecast by Country (2023-2028)
10.4.1 Germany Gene Therapy Drugs Market Forecast
10.4.2 France Gene Therapy Drugs Market Forecast
10.4.3 UK Gene Therapy Drugs Market Forecast
10.4.4 Italy Gene Therapy Drugs Market Forecast
10.4.5 Russia Gene Therapy Drugs Market Forecast
10.5 Middle East & Africa Gene Therapy Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Gene Therapy Drugs Market Forecast
10.5.2 South Africa Gene Therapy Drugs Market Forecast
10.5.3 Israel Gene Therapy Drugs Market Forecast
10.5.4 Turkey Gene Therapy Drugs Market Forecast
10.5.5 GCC Countries Gene Therapy Drugs Market Forecast
10.6 Global Gene Therapy Drugs Forecast by Type (2023-2028)
10.7 Global Gene Therapy Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 F. Hoffmann-La Roche AG
11.1.1 F. Hoffmann-La Roche AG Company Information
11.1.2 F. Hoffmann-La Roche AG Gene Therapy Drugs Product Offered
11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 F. Hoffmann-La Roche AG Main Business Overview
11.1.5 F. Hoffmann-La Roche AG Latest Developments
11.2 Novartis International AG
11.2.1 Novartis International AG Company Information
11.2.2 Novartis International AG Gene Therapy Drugs Product Offered
11.2.3 Novartis International AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis International AG Main Business Overview
11.2.5 Novartis International AG Latest Developments
11.3 Gilead Sciences, Inc.
11.3.1 Gilead Sciences, Inc. Company Information
11.3.2 Gilead Sciences, Inc. Gene Therapy Drugs Product Offered
11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Gilead Sciences, Inc. Main Business Overview
11.3.5 Gilead Sciences, Inc. Latest Developments
11.4 Ultragenyx Pharmaceutical,Inc.
11.4.1 Ultragenyx Pharmaceutical,Inc. Company Information
11.4.2 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Product Offered
11.4.3 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Ultragenyx Pharmaceutical,Inc. Main Business Overview
11.4.5 Ultragenyx Pharmaceutical,Inc. Latest Developments
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Information
11.5.2 Applied Genetic Technologies Corp Gene Therapy Drugs Product Offered
11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Applied Genetic Technologies Corp Main Business Overview
11.5.5 Applied Genetic Technologies Corp Latest Developments
11.6 Audentes Therapeutics
11.6.1 Audentes Therapeutics Company Information
11.6.2 Audentes Therapeutics Gene Therapy Drugs Product Offered
11.6.3 Audentes Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Audentes Therapeutics Main Business Overview
11.6.5 Audentes Therapeutics Latest Developments
11.7 BioMarin Pharmaceutical
11.7.1 BioMarin Pharmaceutical Company Information
11.7.2 BioMarin Pharmaceutical Gene Therapy Drugs Product Offered
11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 BioMarin Pharmaceutical Main Business Overview
11.7.5 BioMarin Pharmaceutical Latest Developments
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Information
11.8.2 Bluebird Bio Gene Therapy Drugs Product Offered
11.8.3 Bluebird Bio Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Bluebird Bio Main Business Overview
11.8.5 Bluebird Bio Latest Developments
11.9 Nightstar Therapeutics
11.9.1 Nightstar Therapeutics Company Information
11.9.2 Nightstar Therapeutics Gene Therapy Drugs Product Offered
11.9.3 Nightstar Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Nightstar Therapeutics Main Business Overview
11.9.5 Nightstar Therapeutics Latest Developments
11.10 Sangamo Therapeutics
11.10.1 Sangamo Therapeutics Company Information
11.10.2 Sangamo Therapeutics Gene Therapy Drugs Product Offered
11.10.3 Sangamo Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Sangamo Therapeutics Main Business Overview
11.10.5 Sangamo Therapeutics Latest Developments
11.11 Spark Therapeutics
11.11.1 Spark Therapeutics Company Information
11.11.2 Spark Therapeutics Gene Therapy Drugs Product Offered
11.11.3 Spark Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Spark Therapeutics Main Business Overview
11.11.5 Spark Therapeutics Latest Developments
11.12 uniQure
11.12.1 uniQure Company Information
11.12.2 uniQure Gene Therapy Drugs Product Offered
11.12.3 uniQure Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 uniQure Main Business Overview
11.12.5 uniQure Latest Developments
11.13 VBL Therapeutics
11.13.1 VBL Therapeutics Company Information
11.13.2 VBL Therapeutics Gene Therapy Drugs Product Offered
11.13.3 VBL Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 VBL Therapeutics Main Business Overview
11.13.5 VBL Therapeutics Latest Developments
11.14 Voyager Therapeutics
11.14.1 Voyager Therapeutics Company Information
11.14.2 Voyager Therapeutics Gene Therapy Drugs Product Offered
11.14.3 Voyager Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Voyager Therapeutics Main Business Overview
11.14.5 Voyager Therapeutics Latest Developments
12 Research Findings and Conclusion
Table 1. Gene Therapy Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Neuromuscular Disease
Table 3. Major Players of Genetic Disease
Table 4. Major Players of Other
Table 5. Gene Therapy Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Gene Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 8. Gene Therapy Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Gene Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 11. Global Gene Therapy Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Gene Therapy Drugs Revenue Market Share by Player (2020-2022)
Table 13. Gene Therapy Drugs Key Players Head office and Products Offered
Table 14. Gene Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Gene Therapy Drugs Market Size Market Share by Regions (2017-2022)
Table 19. Americas Gene Therapy Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Gene Therapy Drugs Market Size Market Share by Country (2017-2022)
Table 21. Americas Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Gene Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 23. Americas Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Gene Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 25. APAC Gene Therapy Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Gene Therapy Drugs Market Size Market Share by Region (2017-2022)
Table 27. APAC Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Gene Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 29. APAC Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Gene Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 31. Europe Gene Therapy Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Gene Therapy Drugs Market Size Market Share by Country (2017-2022)
Table 33. Europe Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Gene Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 35. Europe Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Gene Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Gene Therapy Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Gene Therapy Drugs
Table 44. Key Market Challenges & Risks of Gene Therapy Drugs
Table 45. Key Industry Trends of Gene Therapy Drugs
Table 46. Global Gene Therapy Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Gene Therapy Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Gene Therapy Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Gene Therapy Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Gene Therapy Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Gene Therapy Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 52. F. Hoffmann-La Roche AG Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 53. F. Hoffmann-La Roche AG Gene Therapy Drugs Product Offered
Table 54. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. F. Hoffmann-La Roche AG Main Business
Table 56. F. Hoffmann-La Roche AG Latest Developments
Table 57. Novartis International AG Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 58. Novartis International AG Gene Therapy Drugs Product Offered
Table 59. Novartis International AG Main Business
Table 60. Novartis International AG Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Novartis International AG Latest Developments
Table 62. Gilead Sciences, Inc. Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 63. Gilead Sciences, Inc. Gene Therapy Drugs Product Offered
Table 64. Gilead Sciences, Inc. Main Business
Table 65. Gilead Sciences, Inc. Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Gilead Sciences, Inc. Latest Developments
Table 67. Ultragenyx Pharmaceutical,Inc. Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 68. Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Product Offered
Table 69. Ultragenyx Pharmaceutical,Inc. Main Business
Table 70. Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Ultragenyx Pharmaceutical,Inc. Latest Developments
Table 72. Applied Genetic Technologies Corp Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 73. Applied Genetic Technologies Corp Gene Therapy Drugs Product Offered
Table 74. Applied Genetic Technologies Corp Main Business
Table 75. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Applied Genetic Technologies Corp Latest Developments
Table 77. Audentes Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 78. Audentes Therapeutics Gene Therapy Drugs Product Offered
Table 79. Audentes Therapeutics Main Business
Table 80. Audentes Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Audentes Therapeutics Latest Developments
Table 82. BioMarin Pharmaceutical Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 83. BioMarin Pharmaceutical Gene Therapy Drugs Product Offered
Table 84. BioMarin Pharmaceutical Main Business
Table 85. BioMarin Pharmaceutical Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. BioMarin Pharmaceutical Latest Developments
Table 87. Bluebird Bio Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 88. Bluebird Bio Gene Therapy Drugs Product Offered
Table 89. Bluebird Bio Main Business
Table 90. Bluebird Bio Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Bluebird Bio Latest Developments
Table 92. Nightstar Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 93. Nightstar Therapeutics Gene Therapy Drugs Product Offered
Table 94. Nightstar Therapeutics Main Business
Table 95. Nightstar Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Nightstar Therapeutics Latest Developments
Table 97. Sangamo Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 98. Sangamo Therapeutics Gene Therapy Drugs Product Offered
Table 99. Sangamo Therapeutics Main Business
Table 100. Sangamo Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Sangamo Therapeutics Latest Developments
Table 102. Spark Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 103. Spark Therapeutics Gene Therapy Drugs Product Offered
Table 104. Spark Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Spark Therapeutics Main Business
Table 106. Spark Therapeutics Latest Developments
Table 107. uniQure Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 108. uniQure Gene Therapy Drugs Product Offered
Table 109. uniQure Main Business
Table 110. uniQure Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. uniQure Latest Developments
Table 112. VBL Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 113. VBL Therapeutics Gene Therapy Drugs Product Offered
Table 114. VBL Therapeutics Main Business
Table 115. VBL Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. VBL Therapeutics Latest Developments
Table 117. Voyager Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors
Table 118. Voyager Therapeutics Gene Therapy Drugs Product Offered
Table 119. Voyager Therapeutics Main Business
Table 120. Voyager Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Voyager Therapeutics Latest Developments
List of Figures
Figure 1. Gene Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gene Therapy Drugs Market Size Market Share by Type in 2021
Figure 7. Gene Therapy Drugs in Hospital
Figure 8. Global Gene Therapy Drugs Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Gene Therapy Drugs in Pharmacy
Figure 10. Global Gene Therapy Drugs Market: Pharmacy (2017-2022) & ($ Millions)
Figure 11. Global Gene Therapy Drugs Market Size Market Share by Application in 2021
Figure 12. Global Gene Therapy Drugs Revenue Market Share by Player in 2021
Figure 13. Global Gene Therapy Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Gene Therapy Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Gene Therapy Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Gene Therapy Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Gene Therapy Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Gene Therapy Drugs Value Market Share by Country in 2021
Figure 19. Americas Gene Therapy Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Gene Therapy Drugs Market Size Market Share by Application in 2021
Figure 21. United States Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Gene Therapy Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Gene Therapy Drugs Market Size Market Share by Application in 2021
Figure 27. China Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Gene Therapy Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Gene Therapy Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Gene Therapy Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Gene Therapy Drugs Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...